Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/KCT0000119
KCT0000119Recruiting未知

Randomized phase I/II study to evaluate the safety and immunogenicity of ‘MG1109(egg-based, pre-pandemic influenza(H5N1) vaccine)’ administered intramuscularly in healthy adult volunteers

Koera University Guro Hospital0 sites346 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
未知
Status
Recruiting
Sponsor
Enrollment
346
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional Study

Eligibility Criteria

Ages
18(Year) to 58(Year) (—)
Sex
All

Inclusion Criteria

  • •Healthy adults who are available for follow-up during the study

Exclusion Criteria

  • •1. Subjects with history of exposure to the H5N1 subtype or H5N1 subtype vaccine
  • •2. Subjects with immune system disorder including immune deficiency disease

Investigators

Sponsor
Koera University Guro Hospital

Similar Trials

Completed
Phase 1
Investigating the safety and tolerability of ONC201 in healthy adults - Part ACancer
ACTRN12621001002875Chimerix, Inc.15
Completed
Phase 1
Investigating the safety and tolerability of ONC201 in healthy adults under fasting and fed conditionsCancer
ACTRN12621000975897Chimerix, Inc.18
Completed
Phase 1
Investigating the safety and tolerability of ONC201 in healthy adults under fasting and fed conditions - Part 2bCancer
ACTRN12621001003864Chimerix, Inc.30
Active, not recruiting
Phase 1
Evaluating Avelumab in combination with Cetuximab in Head and neck cancer (EACH)recurrent/metastatic head and neck squamous cell cancerMedDRA version: 20.0 Level: PT Classification code 10067821 Term: Head and neck cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0 Level: PT Classification code 10060121 Term: Squamous cell carcinoma of head and neck System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2017-003592-64-GBniversity College London130
Active, not recruiting
Not Applicable
A randomized Phase IIa trial evaluating the safety and efficacy of a new centrally acting analgesic in subjects with pain due to diabetic polyneuropathypainful diabetic polyneuropathyMedDRA version: 9.1Level: LLTClassification code 10012685Term: Diabetic polyneuropathy
EUCTR2008-004794-18-DEGrünenthal GmbH108